OptimizeRx
OPRX
56 hedge funds and large institutions have $85.8M invested in OptimizeRx in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
5.62% more ownership
Funds ownership: 53.34% → 58.96% (+5.6%)
13% less funds holding
Funds holding: 64 → 56 (-8)
22% less capital invested
Capital invested by funds: $109M → $85.8M (-$23.6M)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $107K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$10.8M |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$4.13M |
| 3 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$2.78M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.48M |
| 5 |
SST
S Squared Technology
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$3M |
| 2 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
-$2.45M |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$2.33M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$1.69M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.22M |
OPRX Hedge Fund Activity: Q4 2019 in Review
56 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2019, worth a combined $85.8M — down 22% from $109M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of OPRX and 6 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 21 added.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $10.8M. The largest seller was Park West Asset Management, cutting an estimated $3M.
- 56 institutional investors held OptimizeRx (OPRX) as of Q4 2019, down from 64 in Q3 2019.
- Funds reported $85.8M of OptimizeRx stock for Q4 2019, down 22% quarter-over-quarter.
- 6 funds opened new OptimizeRx positions in Q4 2019 and 14 closed out, a net change of -8 holders.
- The largest OptimizeRx buyer in Q4 2019 was AWM Investment Company, an estimated $10.8M added.
- The largest OptimizeRx seller in Q4 2019 was Park West Asset Management, an estimated $3M sold.
Based on aggregated 13F filings for Q4 2019.